Back to GetFilings.com





UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2004

OR

o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 0-19635

GENTA INCORPORATED
(Exact name of Registrant as specified in its charter)

Delaware

 

33-0326866

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification Number)

 

 

 

Two Connell Drive

 

 

Berkeley Heights, NJ

 

07922

(Address of principal executive offices)

 

(Zip Code)

(908) 286-9800
(Registrant’s telephone number, including area code)

          Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes   x           No   o

          Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). 

Yes   x           No   o

As of July 30, 2004, the registrant had 80,358,215 shares of common stock outstanding.



Genta Incorporated
INDEX TO FORM 10-Q

 

 

Page

 

 

PART I.

FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements:

 

 

 

 

 

     Consolidated Balance Sheets at June 30, 2004 and December 31, 2003

3

 

 

 

 

 

 

     Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2004 and 2003

4

 

 

 

 

 

 

     Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2004 and 2003

5

 

 

 

 

 

 

     Notes to Consolidated Financial Statements

6

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

13

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

21

 

 

 

 

 

Item 4.

Controls and Procedures

21

 

 

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

 

 

Item 1.

Legal Proceedings

22

 

 

 

 

 

Item 2.

Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities

22

 

 

 

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

22

 

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

23

 

 

 

 

 

SIGNATURES

25

 

 

 

 

 

CERTIFICATIONS

28

 

2



GENTA INCORPORATED
CONSOLIDATED BALANCE SHEETS

(In thousands, except par value data)

 

June 30,
2004

 

December 31,
2003

 

 

 


 


 

 

 

(Unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

     Cash and cash equivalents (Note 2)

 

 

$

44,429

 

 

 

$

25,153

 

 

     Marketable securities (Note 3)

 

 

 

5,758

 

 

 

 

57,776

 

 

     Accounts receivable - net

 

 

 

8,574

 

 

 

 

16,675

 

 

     Notes receivable

 

 

 

200

 

 

 

 

200

 

 

     Inventory (Note 4)

 

 

 

1,728

 

 

 

 

518

 

 

     Prepaid expenses and other current assets

 

 

 

781

 

 

 

 

3,313

 

 

 

 

 



 

 

 



 

 

Total current assets

 

 

 

61,470

 

 

 

 

103,635

 

 

Property and equipment, net

 

 

 

5,296

 

 

 

 

4,917

 

 

Notes receivable

 

 

 

4,348

 

 

 

 

3,542

 

 

Intangibles, net (Note 5)

 

 

 

574

 

 

 

 

863

 

 

Prepaid royalties

 

 

 

1,268

 

 

 

 

1,268

 

 

Other assets

 

 

 

1,627

 

 

 

 

450

 

 

 

 

 



 

 

 



 

 

Total assets

 

 

$

74,583

 

 

 

$

114,675

 

 

 

 

 



 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

     Accounts payable and accrued expenses

 

 

$

19,747

 

 

 

$

15,319

 

 

     Notes payable

 

 

 

-

 

 

 

 

748

 

 

     Deferred revenues, current portion

 

 

 

5,277

 

 

 

 

5,287

 

 

     Short-term debt (Note 6)

 

 

 

35,000

 

 

 

 

-

 

 

 

 

 



 

 

 



 

 

Total current liabilities

 

 

 

60,024

 

 

 

 

21,354

 

 

     Deferred revenues

 

 

 

33,458

 

 

 

 

36,067

 

 

     Convertible debt (Note 7)

 

 

 

10,000

 

 

 

 

10,000

 

 

     Long-term debt (Note 6)

 

 

 

-

 

 

 

 

35,000

 

 

 

 

 



 

 

 



 

 

Total liabilities

 

 

 

103,482

 

 

 

 

102,421

 

 

 

 

 



 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ (deficit) equity:

 

 

 

 

 

 

 

 

 

 

 

     Series A convertible preferred stock, $.001 par value; 5,000 shares authorized,
        10 shares and 261 shares issued and outstanding, liquidation value of $485 and
        $13,025 at June 30, 2004 and December 31, 2003 respectively

 

 

 

-

 

 

 

 

-

 

 

     Common stock, $.001 par value; 150,000 and 120,000 shares authorized,
        80,358 and 75,927 shares issued and outstanding at June 30, 2004
        and December 31, 2003, respectively

 

 

 

80

 

 

 

 

76

 

 

     Additional paid-in capital

 

 

 

336,189

 

 

 

 

335,713

 

 

     Deferred financing costs

 

 

 

(33

)

 

 

 

-

 

 

     Accumulated deficit

 

 

 

(364,986

)

 

 

 

(323,299

)

 

     Deferred compensation

 

 

 

(117

)

 

 

 

(261

)

 

     Accumulated other comprehensive (loss) income

 

 

 

(32

)

 

 

 

25

 

 

 

 

 



 

 

 



 

 

Total stockholders’ (deficit) equity

 

 

 

(28,899

)

 

 

 

12,254

 

 

 

 

 



 

 

 



 

 

Total liabilities and stockholders’ (deficit) equity

 

 

$

74,583

 

 

 

$

114,675

 

 

 

 

 



 

 

 



 

 

See accompanying notes to consolidated financial statements

3



GENTA INCORPORATED
CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 


 


 

(In thousands, except per share data)

 

2004

 

2003

 

2004

 

2003

 

 

 


 


 


 


 

 

 

(Unaudited)

 

(Unaudited)

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

     Product sales - net

 

$

251

 

$

-

 

$

624

 

$

-

 

     License fees and royalties

 

 

261

 

 

276

 

 

522

 

 

542

 

     Development funding

 

 

1,049

 

 

1,044

 

 

2,097

 

 

2,087

 

 

 



 



 



 



 

Total revenues

 

 

1,561

 

 

1,320

 

 

3,243

 

 

2,629

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

52

 

 

-

 

 

146

 

 

-

 

 

 



 



 



 



 

Gross margin

 

 

1,509

 

 

1,320

 

 

3,097

 

 

2,629

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

     Research and development (including non-cash compensation
        expense of $52 for the three months and $104 for the six
        months ended June 30, 2004 and June 30, 2003, respectively)

 

 

28,945

 

 

18,163

 

 

41,297

 

 

33,672

 


     Selling, general and administrative (including non-cash compensation
        expense of $22 and $92 for the three months ended June 30, 2004
        and June 30, 2003, respectively and $40 and $184 for the six
        months ended June 30, 2004 and June 30, 2003, respectively)

 

 

10,284

 

 

6,223

 

 

19,507

 

 

11,095

 

 

 



 



 



 



 

Total costs and expenses - gross

 

 

39,229

 

 

24,386

 

 

60,804

 

 

44,767

 

     Aventis reimbursement

 

 

(8,531

)

 

(19,433

)

 

(15,964

)

 

(28,590

)

 

 



 



 



 



 

Total costs and expenses - net

 

 

30,698

 

 

4,953

 

 

44,840

 

 

16,177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

34

 

 

215

 

 

56

 

 

527

 

 

 



 



 



 



 

Net loss

 

$

(29,155

)

$

(3,418

)

$

(41,687

)

$

(13,021

)

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per basic and diluted share

 

$

(0.37

)

$

(0.05

)

$

(0.53

)

$

(0.18

)

 

 



 



 



 



 

Shares used in computing net loss per
   basic and diluted share

 

 

79,016

 

 

74,442

 

 

77,945

 

 

74,338

 

 

 



 



 



 



 

See accompanying notes to consolidated financial statements

4



GENTA INCORPORATED
CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

Six Months Ended
June 30,

 

 

 


 

(In thousands)

 

2004

 

2003

 

 

 


 


 

 

 

(Unaudited)

 

Operating activities:

 

 

 

 

 

 

 

Net loss

 

 

$

(41,687

)

 

 

$

(13,021

)

 

Items reflected in net loss not requiring cash:

 

 

 

 

 

 

 

 

 

 

 

          Depreciation and amortization

 

 

 

1,626

 

 

 

 

1,040

 

 

          Compensation expense related to stock options (Note 2)

 

 

 

143

 

 

 

 

288

 

 

     Changes in operating assets and liabilities: